Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Journal of Clinical Oncology, 08/10/09
Escudier B et al. – Sunitinib 37.5 mg, administered on a continuous once–daily dosing regimen, has a manageable safety profile as second–line mRCC therapy, providing flexible dosing, which can be explored in combination studies.
Related Articles
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 83%
Prognostic Value of Capsular Invasion for Localized Clear-Cell Renal Cell Carcinoma
European Urology, 11/10/09
Relevance Score: 83%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 83%
Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey
European Journal of Cancer Care, 10/22/09
Relevance Score: 83%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 83%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients
Cancer, 11/25/09
The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Juxtaglomerular cell tumor of the kidney--a new classification scheme
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrology Dialysis Transplantation, 11/25/09
Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
Hypertension, 11/24/09
Bilateral renal inflammatory pseudotumour effectively treated with corticosteroid
Clinical and Experimental Nephrology, 11/24/09
Article Search
Sponsor


See Latest Articles


